Research progress on clinical outcomes of hybrid coronary revascularization
- VernacularTitle:复合冠状动脉血运重建术临床结果的研究进展
- Author:
Dongjie LI
1
;
Jie GAO
1
;
Pixiong SU
1
Author Information
1. Department of Cardiac Surgery, Heart Center, Chaoyang Hospital, Capital Medical University, Beijing, 100020, P.R.China
- Publication Type:Journal Article
- Keywords:
Hybrid coronary revascularization;
coronary artery bypass grafting;
percutaneous coronary intervention;
minimally invasive direct coronary artery bypass grafting;
review
- From:
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery
2021;28(06):645-649
- CountryChina
- Language:Chinese
-
Abstract:
Hybrid coronary revascularization (HCR) combines the advantages of minimally invasive direct coronary artery bypass grafting (MIDCAB) and percutaneous coronary intervention (PCI), and avoids its relative shortcomings, which has received particular attention in recent years. HCR seems to have become the third revascularization strategy for multi-vessel disease in coronary heart diseases. However, the clinical researches on HCR are still limited. This article will systematically review the comparison of HCR with coronary artery bypass grafting (CABG) and PCI, the results of HCR in specific patients, and the clinical results of different HCR strategies.
